X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii
- PMID: 24331399
- PMCID: PMC3875599
- DOI: 10.1016/j.anai.2013.10.008
X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii
Similar articles
-
Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia.Int J Hematol. 2009 Jun;89(5):716-7. doi: 10.1007/s12185-009-0322-5. Epub 2009 Apr 28. Int J Hematol. 2009. PMID: 19399581 No abstract available.
-
Pseudomonas aeruginosa Liver Abscess as the First Manifestation of X-Linked Agammaglobulinemia With a Novel Mutation.J Investig Allergol Clin Immunol. 2017;27(2):129-131. doi: 10.18176/jiaci.0129. J Investig Allergol Clin Immunol. 2017. PMID: 28398200 No abstract available.
-
Decline of antibodies in XLA infant: when to start IVIG.Allergy. 2011 Mar;66(3):434-5. doi: 10.1111/j.1398-9995.2010.02481.x. Epub 2010 Sep 7. Allergy. 2011. PMID: 21284651 Free PMC article.
-
Pseudomonas aeruginosa sepsis presenting as oral ecthyma gangrenosum in identical twins with Bruton tyrosine kinase gene mutation: Two case reports and review of the literature.J Microbiol Immunol Infect. 2020 Dec;53(6):1030-1034. doi: 10.1016/j.jmii.2020.04.009. Epub 2020 Apr 17. J Microbiol Immunol Infect. 2020. PMID: 32340921 Review.
-
X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.Springer Semin Immunopathol. 1998;19(4):369-81. doi: 10.1007/BF00792597. Springer Semin Immunopathol. 1998. PMID: 9618763 Review. No abstract available.
Cited by
-
Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects.Front Cell Dev Biol. 2021 Mar 11;9:630942. doi: 10.3389/fcell.2021.630942. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33777941 Free PMC article. Review.
-
Diversity in the Clinical Course and Outcome of COVID-19 in Patients with Different Inborn Errors of Immunity can be Associated with the Type of Error.Adv Biomed Res. 2024 Nov 30;13:112. doi: 10.4103/abr.abr_134_23. eCollection 2024. Adv Biomed Res. 2024. PMID: 39717240 Free PMC article.
-
Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia.J Clin Immunol. 2018 Oct;38(7):748-752. doi: 10.1007/s10875-018-0558-z. Epub 2018 Oct 11. J Clin Immunol. 2018. PMID: 30311057 No abstract available.
-
Susceptibility to Cryptococcus neoformans Infection with Bruton's Tyrosine Kinase Inhibition.Infect Immun. 2023 Aug 16;91(8):e0004223. doi: 10.1128/iai.00042-23. Epub 2023 Jul 5. Infect Immun. 2023. PMID: 37404186 Free PMC article.
-
Pneumocystis jirovecii pneumonia after CD4+ T-cell recovery subsequent to CD19-targeted chimeric antigen receptor T-cell therapy: A case report and brief review of literature.Cancer Rep (Hoboken). 2023 Oct;6(10):e1885. doi: 10.1002/cnr2.1885. Epub 2023 Aug 10. Cancer Rep (Hoboken). 2023. PMID: 37563749 Free PMC article. Review.
References
-
- Kanegane H, Nakano T, Shimono Y, Zhao M, Miyawaki T. Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia. Int J Hematol. 2009;89:716–7. - PubMed
-
- Hendriks RW, Bredius RG, Pike-Overzet K, Staal FJ. Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man. Expert Opin Ther Targets. 2011;15:1003–21. - PubMed
-
- Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973–80. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources